Financing type:  underwritten prospectus offering

Gross proceeds:  $57,501,288

Offering:  49,146,400 listed shares

Offering price:  $1.17 per listed share

Overallotment option:  The underwriters may purchase a maximum of 6,410,400 listed shares for overallotment purposes. As of Feb. 27, 2026, such option has expired as all 6,410,400 listed shares have been issued thereunder. All information presented herein includes such exercise.

Commissions in securities:  not applicable (commission in cash only to underwriters Stifel Nicolaus Canada Inc., BMO Nesbitt Burns Inc., Desjardins Securities Inc. and Canaccord Genuity Corp.)

Disclosure:  Refer to the prospectus dated Feb. 12, 2026, and the company's news releases dated Jan. 27, 2026, Jan. 28, 2026, Feb. 12, 2026, and Feb. 18, 2026.